Verity Asset Management’s ImmunityBio IBRX Stock Holding History

Verity Asset Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$858K	Sell	90,906 -5,896	-6%	-$47.1K	0.33%	83
2026 Q2	$848K	Buy	96,802 +28,050	+41%	+$212K	0.32%	91
2026 Q1	$527K	Buy	+68,752	New	+$471K	0.22%	122

Other funds holding IBRX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Verity Asset Management's IBRX Position: Q3 2026 in Review

Verity Asset Management reduced its ImmunityBio (IBRX) stake by 6.1% in Q3 2026, selling an estimated $47.1K and leaving 90,906 shares worth $858K. The position accounts for 0.33% of the portfolio, ranked #83.

Verity Asset Management first reported a position in IBRX in Q1 2026 and has held it in 3 quarters since. 274 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

Verity Asset Management held 90,906 shares of ImmunityBio worth $858K as of Q3 2026.
Verity Asset Management sold 5,896 ImmunityBio shares in Q3 2026, an estimated $47.1K.
ImmunityBio made up 0.33% of Verity Asset Management's portfolio in Q3 2026, its #83 holding.
Verity Asset Management first reported a position in ImmunityBio in Q1 2026 and has held it in 3 quarters since.
274 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Verity Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.